[go: up one dir, main page]

AU2458988A - The preparation, by genetic manipulation, of anticoagulative protein pp4 - Google Patents

The preparation, by genetic manipulation, of anticoagulative protein pp4

Info

Publication number
AU2458988A
AU2458988A AU24589/88A AU2458988A AU2458988A AU 2458988 A AU2458988 A AU 2458988A AU 24589/88 A AU24589/88 A AU 24589/88A AU 2458988 A AU2458988 A AU 2458988A AU 2458988 A AU2458988 A AU 2458988A
Authority
AU
Australia
Prior art keywords
anticoagulative
protein
preparation
genetic manipulation
genetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU24589/88A
Inventor
Karl-Josef Abel
Ulrich Grundmann
Hans Kupper
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Publication of AU2458988A publication Critical patent/AU2458988A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4721—Lipocortins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU24589/88A 1987-11-03 1988-11-02 The preparation, by genetic manipulation, of anticoagulative protein pp4 Abandoned AU2458988A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3737239 1987-11-03
DE19873737239 DE3737239A1 (en) 1987-11-03 1987-11-03 GENETIC PRODUCTION OF ANTICOAGULATORY PROTEIN PP4

Publications (1)

Publication Number Publication Date
AU2458988A true AU2458988A (en) 1989-05-04

Family

ID=6339665

Family Applications (1)

Application Number Title Priority Date Filing Date
AU24589/88A Abandoned AU2458988A (en) 1987-11-03 1988-11-02 The preparation, by genetic manipulation, of anticoagulative protein pp4

Country Status (8)

Country Link
EP (1) EP0318703A1 (en)
JP (1) JPH01165386A (en)
KR (1) KR890008317A (en)
AU (1) AU2458988A (en)
DE (1) DE3737239A1 (en)
DK (1) DK610288A (en)
FI (1) FI885024L (en)
PT (1) PT88912B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1244763A (en) * 1984-09-21 1988-11-15 Christian P.M. Reutelingsperger Blood coagulation inhibiting proteins, processes for preparing them and their uses
DE59001418D1 (en) * 1989-07-15 1993-06-17 Boehringer Ingelheim Int AGENT CONTAINING ANTI-COAGUALITY.
US5627036A (en) * 1989-12-27 1997-05-06 Boehringer Ingelheim International Gmbh Use of an anticoagulant as a diagnostic agent
DE4012341A1 (en) * 1990-04-18 1991-10-24 Behringwerke Ag MONOCLONAL ANTIBODY AGAINST PP4, PROCESS FOR THEIR PREPARATION AND ITS USE
PT672136E (en) * 1992-07-08 2000-08-31 Innogenetics Nv POLYMPEPTIDES DERIVED FROM ENDONEXIN 2 HAVING RECEPTOR ACTIVITY OF HEPATITIS B VIRUS AND ITS USE IN DIAGNOSIS AND PHARMACEUTICAL COMPOSITIONS
US20030220233A1 (en) 1994-01-24 2003-11-27 Neorx Corporation Radiolabeled annexins
US5968477A (en) 1994-01-24 1999-10-19 Neorx Corporation Radiolabeled annexin conjugates with hexose and a chelator
WO1996015152A1 (en) * 1994-11-11 1996-05-23 International Reagents Corporation Antiannexin-v monoclonal antibody, process for producing the same, and use therof
US7635680B2 (en) 2001-02-21 2009-12-22 Alavita Pharmaceuticals, Inc. Attenuation of reperfusion injury
US7635676B2 (en) 2001-02-21 2009-12-22 Alavita Pharmaccuticals, Inc. Modified annexin proteins and methods for their use in organ transplantation
US6962903B2 (en) 2001-02-21 2005-11-08 Alavita, Inc. Modified annexin proteins and methods for preventing thrombosis
US7645739B2 (en) 2001-02-21 2010-01-12 Alavita Pharmaceuticals, Inc. Modified annexin compositions and methods of using same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3315000A1 (en) * 1983-04-26 1984-10-31 Behringwerke Ag, 3550 Marburg TISSUE PROTEIN PP (DOWN ARROW) 4 (DOWN ARROW), METHOD FOR ITS RECOVERY AND USE
DE3586402T3 (en) * 1984-01-12 2004-12-23 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville Protein composition with coagulation effect and process for its preparation.
CA1265446A (en) * 1985-09-30 1990-02-06 Masahiro Maki Anticoagulating substance, process for preparing same and anticoagulant comprising same as an effective component
DE3643182A1 (en) * 1986-12-18 1988-06-30 Behringwerke Ag MEDICINAL PRODUCTS CONTAINING THE TISSUE PROTEIN PP4, METHOD FOR THE PRODUCTION OF PP4 AND ITS PASTEURIZATION AND THE USE OF PP4

Also Published As

Publication number Publication date
FI885024A0 (en) 1988-11-01
PT88912A (en) 1988-12-01
EP0318703A1 (en) 1989-06-07
KR890008317A (en) 1989-07-10
FI885024L (en) 1989-05-04
DK610288D0 (en) 1988-11-02
FI885024A7 (en) 1989-05-03
DE3737239A1 (en) 1989-10-12
DK610288A (en) 1989-05-04
PT88912B (en) 1993-01-29
JPH01165386A (en) 1989-06-29

Similar Documents

Publication Publication Date Title
AU1928388A (en) Surgical dressing
AU8267787A (en) Protein product
AU2572088A (en) Thermo-actuator
AU2179788A (en) Combine harvester
AU8317587A (en) Therapeutic preparations
AU2608292A (en) Human immunoglobulins produced by recombinant dna techniques
AU2204688A (en) Improved system
AU2332388A (en) Improved brassiere
AU2812989A (en) Dressing
AU626147B2 (en) Fibrinolytic proteins
AU3157389A (en) Genetic manipulation
AU1308988A (en) Therapeutic compositions
AU2458988A (en) The preparation, by genetic manipulation, of anticoagulative protein pp4
AU1665088A (en) New compounds, processes for their preparation and uses thereof
AU2297388A (en) Therapeutic agents
AU2197688A (en) New compounds, processes for their preparation and use thereof
AU1384688A (en) 1,5-substituted 1H-imidazoles
AU1039488A (en) Improved thrombin preparations
AU1683188A (en) Disposable peppermill
AU1959488A (en) (n-alpha-acyl, 8-glycine, des-19-leucine)-calcitonin
AU1630188A (en) Substituted compounds, processes for their preparation and their use as medicaments
AU2142888A (en) Novel complex
AU1902088A (en) Tertiary 2,5-dialkyl-3-phenylpiperidine derivatives having opiate-antagonistic activity
AU2032788A (en) Process for the preparation of naphthacenes
AU1164588A (en) Nucleotide analogs, their production and use